Immunosuppressive regimens
Immunosuppressive regimens has been studied in 4 papers since 2020: 1 observational study in people, 1 in animals, 2 reviews; 3 in the past year. The newest paper, Oct 19, 2026: “Heart Transplantation: A Review of Recent Advancements in Pre-, Peri, and Post-Transplant Screening and Management”.
4 papers study it1 findingUpdated
2 new papers in 30 daysSee all 4
- Humans1
- Animals1
What did studies of Immunosuppressive regimens find?
1Studies of Immunosuppressive regimens measured 1 outcome; the most studied are xenograft acceptance (1 study).
Xenograft acceptance
upin humans1
1 study
Xenograft acceptance
upin humans1
Immunosuppressive regimens improve xenograft acceptance in xenotransplantation.
“advances in immunosuppressive regimens, such as co-stimulation blockade and anti-complement treatment, hold great promise for xenograft acceptance”
Reviewin xenotransplantation
Xeno kidney: revolutionizing kidney disease treatment
Frontiers in nephrology
Latest
3 papers in 12 monthsStem Cell Research & Therapy
Clinically adaptable size cartilage grafts generated from human embryonic stem cells enable tracheal repair in a porcine model
Experiments in pigsBones and joints
Nephrology, Dialysis, Transplantation
Replicative senescence and arteriosclerosis after kidney transplantation
Cohort study of 134 peopleBiomarkers